Targovax ASA: Protocol from the Annual General Meeting
April 05, 2017 05:12 ET
|
Targovax ASA
The annual general meeting was held on April 5, 2017 at the Company's offices at Lilleakerveien 2C, 0283 Oslo. Please find minutes of the meeting attached. ### For further information...
Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017
April 04, 2017 03:05 ET
|
Targovax ASA
Reference is made to the notice published on 15 March 2017 regarding the annual general meeting in Targovax ASA (the "Company") to be held on 5 April 2017 at 10:00 am (CEST). The proposal by the...
Targovax ASA: Grant of share options
April 04, 2017 02:54 ET
|
Targovax ASA
Oslo, Norway, 4 April 2017: The Board of Directors of Targovax ASA (the "Company") has resolved to grant 172,000 options to subscribe for shares in the Company to employees under the Company's long...
Targovax ASA moves share listing to Oslo Børs
March 23, 2017 02:01 ET
|
Targovax ASA
Oslo, Norway, 23 March 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid tumors,...
Targovax ASA: Approval and publication listing prospectus
March 22, 2017 09:08 ET
|
Targovax ASA
Reference is made to the stock exchange announcement made on 17 March 2017 regarding Targovax ASA's ("Targovax" or the "Company") resolution to apply for a transfer of the listing of the Company's...
Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list
March 22, 2017 09:05 ET
|
Targovax ASA
Reference is made to the stock exchange announcement made on 17 March 2017 regarding Targovax ASA's ("Targovax" or the "Company") resolution to apply for a transfer of the listing of the Company's...
Targovax ASA applies for transfer to Oslo Stock Exchange main list
March 17, 2017 07:10 ET
|
Targovax ASA
The board of directors of Targovax ASA has resolved to send an application to transfer the listing of the company's shares from Oslo Axess to Oslo Stock Exchange main list. The application will be...
Targovax ASA: Notice of Annual General Meeting
March 15, 2017 17:02 ET
|
Targovax ASA
The Annual General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 5 April 2017 at 10:00 CET. Please find the notice including agenda for the General Meeting and...
Targovax ASA: Annual Report 2016
March 15, 2017 16:17 ET
|
Targovax ASA
On 15 March 2017, the Board of Directors of Targovax ASA approved the financial statements for 2016 for issuance, subject to approval by the Annual General meeting on April 5, 2017. Please find...
Targovax to present at upcoming conferences
March 06, 2017 01:00 ET
|
Targovax ASA
Oslo, Norway, 6 March 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target, primarily, treatment-resistant...